Clinical Trial Update: Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

This document reports a completed Phase 1/2 trial comparing the safety, tolerability, and antiviral effects of Locteron to PEG-Intron in patients with chronic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Locteron
• PEG Intron (pegylated interferon alfa-2b)

Snippet

Sponsor: Biolex Therapeutics, Inc. | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED